نتائج البحث - "Haruki Kobayashi"

1

Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy

المؤلفون: Hiroaki Kodama, Tateaki Naito, Hirotsugu Kenmotsu, Hideyuki Harada, Shota Omori, Kazushige Wakuda, Toshiaki Takahashi, Michitoshi Yabe, Haruki Kobayashi, Koji Muramatsu, Tetsuo Shimizu, Akira Ono, Nobuaki Mamesaya, Taichi Miyawaki, Eriko Miyawaki, Yasuhiro Gon, Naoya Nishioka, Takashi Sugino, Haruyasu Murakami

المصدر: International Journal of Clinical Oncology. 26:659-669

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c975ec864ca94bc4feff7af6b7799cTest
https://doi.org/10.1007/s10147-020-01856-xTest

2

Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study

المؤلفون: Naoya Nishioka, Eriko Miyawaki, Masahiro Endo, Shota Omori, Tateaki Naito, Kazuhisa Takahashi, Taichi Miyawaki, Haruki Kobayashi, Nobuaki Mamesaya, Haruyasu Murakami, Hideyuki Harada, Akira Ono, Ryo Ko, Hirotsugu Kenmotsu, Kazushige Wakuda, Toshiaki Takahashi, Keita Mori, Hiroaki Kodama

المصدر: BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)

مصطلحات موضوعية: Male, Oncology, Cancer Research, Lung Neoplasms, Neoplasm, Residual, Time Factors, Disease, Logistic regression, Failure pattern, Surgical oncology, Carcinoma, Non-Small-Cell Lung, Osimertinib, Treatment Failure, Epidermal growth factor receptor, RC254-282, Aged, 80 and over, Aniline Compounds, biology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Gefitinib, Middle Aged, ErbB Receptors, Disease Progression, Female, Adult, medicine.medical_specialty, Adenocarcinoma, Afatinib, Erlotinib Hydrochloride, EGFR-TKI, Internal medicine, Oligo-residual disease, Genetics, medicine, Humans, Lung cancer, Protein Kinase Inhibitors, Aged, Retrospective Studies, Acrylamides, business.industry, Research, Retrospective cohort study, Genes, erbB-1, medicine.disease, respiratory tract diseases, Logistic Models, Mutation, biology.protein, business, Non-small-cell lung cancer, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0968df06432ca7c42481def3e798a1Test
https://doi.org/10.1186/s12885-021-08983-2Test

3

Impact of Cancer Cachexia on Treatment With PD-1/PD-L1 Inhibitors Plus Chemotherapy in Advanced Non-small-Cell Lung Cancer

المؤلفون: Shota Omori, Haruki Kobayashi, Taichi Miyawaki, Nobuaki Mamesaya, Haruyasu Murakami, Akira Ono, Toshiaki Takahashi, Kazushige Wakuda, Hiroaki Kodama, Hideyuki Harada, Michitoshi Yabe, Kazuhisa Takahashi, Eriko Miyawaki, Hirotsugu Kenmotsu, Tateaki Naito, Naoya Nishioka, Keita Mori

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chemotherapy, biology, business.industry, medicine.medical_treatment, Cancer cachexia, medicine.disease, Text mining, Internal medicine, PD-L1, medicine, biology.protein, Non small cell, Lung cancer, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7fa3aa619fb51105fbac7c8ce23de447Test
https://doi.org/10.21203/rs.3.rs-524527/v1Test

4

Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer

المؤلفون: Hirotsugu Kenmotsu, Michitoshi Yabe, Naoya Nishioka, Haruyasu Murakami, Keita Mori, Shota Omori, Kazushige Wakuda, Akira Ono, Kazuhisa Takahashi, Taichi Miyawaki, Haruki Kobayashi, Nobuaki Mamesaya, Eriko Miyawaki, Hiroaki Kodama, Tateaki Naito, Hideyuki Harada, Toshiaki Takahashi

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerReferences. 30(2)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec52fff9373ad8a26912e3d003ab096Test
https://pubmed.ncbi.nlm.nih.gov/34550461Test

5

Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis

المصدر: Investigational new drugs. 39(6)

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, Kaplan-Meier Estimate, Tyrosine-kinase inhibitor, Sex Factors, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Pharmacology (medical), Osimertinib, Epidermal growth factor receptor, Lung cancer, Protein Kinase Inhibitors, Aged, Retrospective Studies, Pharmacology, Aged, 80 and over, biology, business.industry, Age Factors, Middle Aged, medicine.disease, respiratory tract diseases, ErbB Receptors, biology.protein, Female, Erlotinib, Non small cell, business, Meningeal Carcinomatosis, Leptomeningeal metastasis, medicine.drug, Epidermal growth factor receptor tyrosine kinase

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b234eceaed54f034e73b11c7b39f0ea5Test
https://pubmed.ncbi.nlm.nih.gov/34259953Test

6

A BLUS1 kinase signal and a decrease in intercellular CO(2) concentration are necessary for stomatal opening in response to blue light

المؤلفون: Ken-ichiro Shimazaki, Shota Yamauchi, Sakurako Hosotani, Atsushi Takemiya, Haruki Kobayashi, Shigekazu Koya, Saashia Fuji

المصدر: Plant Cell

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5248e8aac804837a7636c51e022e5fc0Test
https://europepmc.org/articles/PMC8254492Test/

7

Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases

المؤلفون: Yoko Nakasu, Eriko Miyawaki, Yasuhiro Gon, Toshiaki Takahashi, Shota Omori, Masahiro Endo, Hirotsugu Kenmotsu, Haruki Kobayashi, Akira Ono, Keita Mori, Takahisa Kawamura, Koichi Mitsuya, Haruyasu Murakami, Hideyuki Harada, Kazushige Wakuda, Kazuhisa Nakashima, Tateaki Naito, Nobuaki Mamesaya

المصدر: International Journal of Radiation Oncology*Biology*Physics. 104:604-613

مصطلحات موضوعية: Male, Oncology, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Kaplan-Meier Estimate, Tyrosine-kinase inhibitor, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Epidermal growth factor receptor, Aged, 80 and over, Radiation, biology, Brain Neoplasms, digestive, oral, and skin physiology, Hazard ratio, Gefitinib, Radiotherapy Dosage, Middle Aged, Progression-Free Survival, ErbB Receptors, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, Female, Non small cell, Adult, medicine.medical_specialty, medicine.drug_class, Antineoplastic Agents, Afatinib, Radiosurgery, Erlotinib Hydrochloride, 03 medical and health sciences, Internal medicine, Confidence Intervals, medicine, Humans, Radiology, Nuclear Medicine and imaging, Lung cancer, Protein Kinase Inhibitors, Aged, Proportional Hazards Models, Retrospective Studies, business.industry, medicine.disease, Confidence interval, respiratory tract diseases, Radiation therapy, stomatognathic diseases, Mutation, biology.protein, Cranial Irradiation, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1bbc6ffcca7f9c1fdb60d6fb23f132Test
https://doi.org/10.1016/j.ijrobp.2019.02.051Test

8

PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer

المؤلفون: Nobuaki Mamesaya, Tateaki Naito, Kazushige Wakuda, Toshiaki Takahashi, Akira Ono, Haruyasu Murakami, Shota Omori, Takahisa Kawamura, Eriko Miyawaki, Haruki Kobayashi, Hirotsugu Kenmotsu, Keita Mori

المصدر: Japanese journal of clinical oncology. 50(5)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Mutant, Pembrolizumab, EGFR Gene Mutation, medicine.disease_cause, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Medicine, Humans, Radiology, Nuclear Medicine and imaging, In patient, Epidermal growth factor receptor, Lung cancer, Aged, Retrospective Studies, Mutation, biology, business.industry, General Medicine, Middle Aged, medicine.disease, ErbB Receptors, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, biology.protein, Female, Non small cell, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c7d030f38c89bc672a655aa2df60972Test
https://pubmed.ncbi.nlm.nih.gov/32211792Test

9

Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments

المؤلفون: Takashi Sugino, Takashi Nakajima, Masahiro Endo, Shota Omori, Toshiaki Takahashi, Yasuhisa Ohde, Yasuto Akiyama, Tateaki Naito, Haruki Kobayashi, Hirotsugu Kenmotsu, Tetsuhiko Taira, Haruyasu Murakami, Kazuhisa Nakashima, Masato Abe, Kazushige Wakuda, Akira Ono, Reiko Watanabe

المصدر: International Journal of Clinical Oncology. 23:1052-1059

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d6a6c289c9d6d5c152b84b9ee965861Test
https://doi.org/10.1007/s10147-018-1305-4Test

10

A favorable clinical effect of an expectorant in allergic bronchopulmonary mycosis caused by Schizophyllum commune

المؤلفون: Masahiro Endo, Toshiaki Takahashi, Tetsuhiko Taira, Kazushige Wakuda, Haruki Kobayashi

المصدر: Respiratory Medicine Case Reports

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec0b3da289c35ad835def7f232b75eeaTest
http://europepmc.org/articles/PMC4961680Test

تنقيح النتائج